Non-insulin treatments, used as first-line therapies for patients who have diabetes, currently capture more than half the sales in the anti-diabetics market
Wraparound support in weight loss Experts have stressed the multi-factorial causes of obesity and therefore the need for a multi-faceted approach, considering other factors like lifestyle, trauma and psychological support 46
The company's FAQ states that "PT-141 is FDA-approved for low sexual desire." This requires clarification: bremelanotide (marketed under the brand name Vyleesi) received FDA approval specifically as a subcutaneous injection for hypoactive sexual desire disorder (HSDD) in premenopausal women
Marketing authorisation holders should also consider implementing awareness campaigns on weight management and educational activities on the ongoing shortage and its implications for clinical practice
You have now administered your first dose of MT2
A Phase 1, randomised, placebo-controlled, double-blind study was comprised of three parts: a single-ascending dose (SAD